{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:11:07Z","timestamp":1785453067707,"version":"3.56.0"},"reference-count":30,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T00:00:00Z","timestamp":1608163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T00:00:00Z","timestamp":1608163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100011095","name":"Becton Dickenson Biosciences","doi-asserted-by":"publisher","award":["None"],"award-info":[{"award-number":["None"]}],"id":[{"id":"10.13039\/100011095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2020,12,17]]},"abstract":"<jats:p>The clinical performance of the BD Veritor System for Rapid Detection of SARS-CoV-2 nucleocapsid antigen (Veritor), a chromatographic immunoassay used for SARS-CoV-2 point-of-care testing, was evaluated using nasal specimens from individuals with COVID-19 symptoms. Two studies were completed to determine clinical performance. In the first study, nasal specimens and either nasopharyngeal or oropharyngeal specimens from 251 participants with COVID-19 symptoms (\u22647\u2009days from symptom onset [DSO], \u226518\u2009years of age) were utilized to compare Veritor with the Lyra SARS-CoV-2 PCR assay (Lyra).<\/jats:p>","DOI":"10.1128\/jcm.02338-20","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T09:16:05Z","timestamp":1602062165000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":111,"title":["Clinical Evaluation of BD Veritor SARS-CoV-2 Point-of-Care Test Performance Compared to PCR-Based Testing and versus the Sofia 2 SARS Antigen Point-of-Care Test"],"prefix":"10.1128","volume":"59","author":[{"given":"Stephen","family":"Young","sequence":"first","affiliation":[{"name":"Tricore Reference Laboratory, Albuquerque, New Mexico, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie N.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine L.","family":"Cammarata","sequence":"additional","affiliation":[{"name":"Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katey G.","family":"Varnado","sequence":"additional","affiliation":[{"name":"Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Roger-Dalbert","sequence":"additional","affiliation":[{"name":"Becton, Dickinson and Company, BD Life Sciences\u2014Integrated Diagnostic Solutions, Sparks, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Montano","sequence":"additional","affiliation":[{"name":"Tricore Reference Laboratory, Albuquerque, New Mexico, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christen","family":"Griego-Fullbright","sequence":"additional","affiliation":[{"name":"Tricore Reference Laboratory, Albuquerque, New Mexico, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Burgard","sequence":"additional","affiliation":[{"name":"Tricore Reference Laboratory, Albuquerque, New Mexico, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Fernandez","sequence":"additional","affiliation":[{"name":"Becton, Dickinson and Company, BD Life Sciences\u2014Integrated Diagnostic Solutions, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Eckert","sequence":"additional","affiliation":[{"name":"Becton, Dickinson and Company, BD Life Sciences\u2014Integrated Diagnostic Solutions, Sparks, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey C.","family":"Andrews","sequence":"additional","affiliation":[{"name":"Becton, Dickinson and Company, BD Life Sciences\u2014Integrated Diagnostic Solutions, Sparks, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimiao","family":"Ren","sequence":"additional","affiliation":[{"name":"Becton, Dickinson and Company, BD Life Sciences\u2014Integrated Diagnostic Solutions, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Allen","sequence":"additional","affiliation":[{"name":"STAT Research, Vandalia, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Ackerman","sequence":"additional","affiliation":[{"name":"Comprehensive Clinical Research, LLC, West Palm Beach, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles K.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Becton, Dickinson and Company, BD Life Sciences\u2014Integrated Diagnostic Solutions, Sparks, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","unstructured":"Policy for Coronavirus Disease. 2019. Tests during the public health emergency (revised): immediately in effect guidance for clinical laboratories commercial manufacturers and food and drug administration staff version May 11 2020. U.S. Food and Drug Administration Bethesda MD. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/policy-coronavirus-disease-2019-tests-during-public-health-emergency-revised."},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2648"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.6.2000082"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/d41587-020-00010-2"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqaa052"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2020.112454"},{"key":"e_1_3_3_8_2","volume-title":"Global research and innovation forum: towards a research roadmap","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. 2020. Global research collaboration for infectious disease preparedness\u2014COVID 19: Public Health Emergency of International Concern (PHEIC). Global research and innovation forum: towards a research roadmap, 02\/11\/2020\u201302\/12\/2020. World Health Organization, Geneva, Switzerland. https:\/\/www.who.int\/blueprint\/priority-diseases\/key-action\/Global_Research_Forum_FINAL_VERSION_for_web_14_feb_2020.pdf?ua=1."},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.22.20136309:2020.06.22.20136309"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2020.102581"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.03.041"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2015151516"},{"key":"e_1_3_3_13_2","volume-title":"BD Veritor\u2122: system for rapid detection of SARS-CoV-2","author":"Becton, Dickinson and Company","year":"2020","unstructured":"Becton, Dickinson and Company. 2020. BD Veritor\u2122: system for rapid detection of SARS-CoV-2. Package insert, EUA. Becton, Dickinson and Company, Sparks-Glencoe, MD."},{"key":"e_1_3_3_14_2","volume-title":"Sofia\u00ae: SARS antigen FIA","author":"Quidel Corporation","year":"2020","unstructured":"Quidel Corporation. 2020. Sofia\u00ae: SARS antigen FIA. Package insert, EUA. Quidel Corporation, San Diego, CA."},{"key":"e_1_3_3_15_2","volume-title":"Lyra\u00ae: SARS-CoV-2 assay","author":"Quidel Corporation","year":"2020","unstructured":"Quidel Corporation. 2020. Lyra\u00ae: SARS-CoV-2 assay. Package insert, EUA. Quidel Corporation, Athens, OH."},{"key":"e_1_3_3_16_2","volume-title":"SARS-CoV-2: reagents for the MAX\u2122 system","author":"Becton, Dickinson and Company","year":"2020","unstructured":"Becton, Dickinson and Company. 2020. SARS-CoV-2: reagents for the MAX\u2122 system. Package insert, EUA. Becton, Dickinson and Company, Sparks-Glencoe, MD."},{"key":"e_1_3_3_17_2","volume-title":"In vitro diagnostics EUAs: antigen template for manufacturers","author":"U.S. Food and Drug Administration","year":"2020","unstructured":"U.S. Food and Drug Administration. 2020. In vitro diagnostics EUAs: antigen template for manufacturers. U.S. Food and Drug Administration, Bethesda, MD. https:\/\/www.fda.gov\/medical-devices\/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices\/vitro-diagnostics-euas."},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1497.2004.30091.x"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1011.040516"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.07.20032524:2020.03.07.20032524"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2332-7"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1085952"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.20.20071423"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa638"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2196-x"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2020.0062"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30232-2"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(20)30354-4"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI138759"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-02893-8"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.08.20125310:2020.06.08.20125310"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.02338-20","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.02338-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T07:25:05Z","timestamp":1646465105000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.02338-20"}},"subtitle":[],"editor":[{"given":"Melissa B.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,12,17]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12,17]]}},"alternative-id":["10.1128\/JCM.02338-20"],"URL":"https:\/\/doi.org\/10.1128\/jcm.02338-20","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.09.01.20185777","asserted-by":"object"}]},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,17]]},"assertion":[{"value":"2020-09-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e02338-20"}}